Abstract
Hendra virus is a zoonotic paramyxovirus, which causes severe respiratory and neurological disease in horses and humans. Since 2012, the Hendra virus sub-unit G vaccine has been available for horse vaccination in Australia. Uptake of the vaccine has been limited and spill-over events of Hendra virus infection in horses continue to occur. We conducted an online, questionnaire-based cross-sectional study of 376 horse owners belonging to a variety of different equestrian clubs in Queensland, Australia, to identify risk factors for non-vaccination against Hendra virus. A total of 43.1% (N = 162) of horse owners indicated that they currently did not vaccinate against Hendra virus infection, while 56.9% (N = 214) currently vaccinated against Hendra virus infection. A total of 52 risk factors were evaluated relating to equestrian activities, horse management, perceived risk and severity of horse and human infection with Hendra virus, side effects of Hendra vaccination, other vaccinations conducted by horse owners and horse owners’ attitudes towards veterinarians. The final multivariable logistics regression model identified the following risk factors associated with increased odds of non-vaccination against Hendra virus: 1) perceived low risk (compared to high) of Hendra virus infection to horses (considering the horse owners’ location and management practices) or horse owners were unsure about the risk of infection, 2) perceived moderate severity (compared to very severe or severe) of Hendra virus infection in humans, 3) horse owners non-vaccination of their pets, 4) horse owners non-vaccination against strangles disease in horses, 5) handling of more than three horses per week (compared to one horse only) and 6) perceived attitude that veterinarians had a high motivation of making money from Hendra virus vaccination (compared to veterinarians having a low motivation of making money from Hendra virus vaccination). Horse owners were more likely to vaccinate against Hendra virus if horses were used for dressage, show jumping or eventing. The study also identified horse owners’ concerns about side-effects and about the lack of evidence on vaccine efficacy.
Highlights
Hendra virus (HeV) is a zoonotic paramyxovirus first recognised in 1994 [1,2,3]
A total of 43.1% (N = 162) of horse owners belonging to equestrian clubs indicated that they currently did not vaccinate against HeV infection, while 56.9% (N = 214) currently vaccinated against HeV infection
Almost half of the respondents did not vaccinate against HeV (43.1%, n = 162)
Summary
Hendra virus (HeV) is a zoonotic paramyxovirus first recognised in 1994 [1,2,3]. Since its emergence HeV has caused sporadic outbreaks of respiratory and neurological disease characterised by significant mortality [3]. Pteropid fruit bats are the natural reservoir of the virus, [4] with spill-over events into horses, horse to horse and horse to human transmission occurring [5]. Whilst HeV infection in horses has generally been associated with respiratory and neurological signs, clinical signs can be non-specific, which can be mistaken for common diseases such as colic, pneumonia or pleuropneumonia [6,7]. The rate of spill-over events from flying foxes is considered to be low, [4] and is thought to occur when horses are exposed to flying fox secretions [8]. The current attack rate for humans exposed to infected secretions and fluids is low and estimated to be approximately 10% [8]. The consequences are severe as the mortality rate is high, currently being 57% [6, 11]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
